About SAGE THERAPEUTICS, INC.

SAGE THERAPEUTICS, INC.

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. The company's mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated.

News Releases

Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease

_↗ investor.sagerx.com

Apr 17, 2024

Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement

_↗ investor.sagerx.com

Aug 31, 2023

FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder

_↗ investor.sagerx.com

Aug 4, 2023

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.